Journals / Turkish Journal of Health Science and Life / 2021 / Cilt: 4 - Sayı: 3

IRON DEFICIENCY AND ANEMIA IN HEART FAILURE

Pages
101–105
Publication Date
2021-12-27
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article, the importance of iron deficiency and anemia, which are common in heart failure patients, will be discussed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Heart failure is an international health problem with its high incidence, prevalence, morbidity and mortality rates.
📊
Key Findings & Data:There are many complications that can be seen in patients with heart failure due to pathophysiology, drug side effects, comorbid comorbid diseases and limitations caused by heart failure.
💡
Conclusion & Impact:In this article, the importance of iron deficiency and anemia, which are common in heart failure patients, will be discussed.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Anemia · Iron Deficiency · Heart Failure

Abstract

Heart failure is an international health problem with its high incidence, prevalence, morbidity and mortality rates. There are many complications that can be seen in patients with heart failure due to pathophysiology, drug side effects, comorbid comorbid diseases and limitations caused by heart failure. Comorbid conditions adversely affect the clinical course, worsen the prognosis, make treatment difficult, and make the clinical picture difficult to control. One of the most common comorbid conditions in heart failure is iron deficiency and anemia. It is important that healthcare professionals, be attentive to iron deficiency and anemia, and raise awareness among patients and their caregivers. In this article, the importance of iron deficiency and anemia, which are common in heart failure patients, will be discussed.

🔖

Cite This Article

BARUTCU, C. D., KIVRAK, Z. (2021). IRON DEFICIENCY AND ANEMIA IN HEART FAILURE. Turkish Journal of Health Science and Life, Cilt: 4 - Sayı: 3, 101–105. https://ajindex.com/articles/808893

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Jessup, M., Abraham, W., Casey, D., et al. ACC/AHA Guidelines for the diagnosis and management of heart failure in adults. JACC 2009; 53: 1347-69
  2. Çavuşoğlu, Y., Altay, H., Çetiner, M., Güvenç, T. S., Temizhan, A., Ural, D., Yeşilbursa, D., Yıldırım, N., Yılmaz, M. B. Kalp yetersizliğinde demir eksikliği ve anemi. Turk Kardiyol Dern Ars 2017; Suppl 2: 1-38 doi: 10.5543/tkda.2017.79584 European Society of Cardiology. European Guidelines on cardiovascular disease prevention in clinical practice. European Heart Journal. 2016, 37, 2315-2381.
  3. Ponikowski, P., Voors, A. A., Anker, S. D., Bueno, H., Cleland, J. G. F., Coats, A. J. S., et al. (2016). 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Eur Heart J 2016;37:2129–200
  4. Heckman, G. A., Boscart, V. M., D'Elia, T., Lelley, M. L., Kaasalainen, S., McAiney, C. A., et al. Managing heart failure in long-term care: recommendations from an ınter professional stake holder consultation. Canadian Journal on Aging 2016;35(4):447-467 https://doi.org/10.1017/S071498081600043X
  5. Değertekin, M., Erol, Ç., Ergene, O., Tokgözoğlu, L., Aksoy, M., Erol, M. K., et al. Türkiye’deki kalp yetersizliği prevelansı öngördücüleri: HAPPY çalışması. Türk Kardiyol Dern Arş 2012;40(4):298-308. http://dx.doi.org/10.5543/tkda.2012.65031
  6. Abraham, W.T., Krum, H. (2007). Kalp Yetersizliği Tedaviye Pratik Bir Yaklaşım. 1. Baskı. İstanbul:
  7. Cordis Group Jankowska, E. A., Tkaczyszyn, M., Suchocki, T., Drozd, M., Von Haehling, S., Doehner, W., et al. Effects of intravenous iron therapy in iron-deficient patients with systolic heart failure: meta-analysis of randomized controlled trials. Eur J Heart Fail 2016;18:786–95
  8. Tokgözoğlu, L., Yılmaz, M. B., Abacı, A., Altay, H., Atalar, E., et al. Türkiye’de kalp yetersizliği yol haritası kalp yetersizliğinin ve buna bağlı ölümlerin önlenmesi amacıyla geliştirilebilecek politikalara ilişkin öneriler. TKD, 2015; 1-31
  9. Westenbrink, B. D., Alings, M., Granger, C. B., Alexander, J. H., Lopes, R. D., Hylek, E. M., et al. Anemia is associated with bleeding and mortality, but not stroke, in patients with atrial fibrillation: In¬sights from the apixaban for reduction in stroke and other thromboembolic events in atrial fibrillation (ARISTOTLE) trial. Am Heart J 2017;185:140–9
  10. Silverberg DS, Wexler D, Blum M et al. The use of subcutaneous erythropoietin a